GREENFERN INDUSTRIES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.034 NZD | -.--% |
|
-2.86% | -39.29% |
| Mar. 20 | New Zealand Shares Flat Ahead of US Fed Meeting; Warehouse Group Jumps 7% Despite Swing to Profit | MT |
| Mar. 20 | Greenfern Industries Ships First Batch of Medicinal Cannabis to Europe, UK | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Greenfern Industries Limited is a New Zealand-based medicinal cannabis and biotechnology company. The Company operates primarily from their medicinal cannabis research facility and hemp processing hub in Normanby, South Taranaki. The Company cultivates premium and consistent cannabis and through research and development, creates a pharmaceutical grade product range. The Company operates through two segments: Cannabis and therapeutics products, and Electricity generation. The Cannabis and therapeutics products segment reflects the activities of the arrangement with Cannvalate to manufacture and distribute white label products. The Electricity generation segment includes the generation and distribution of electricity. The Company operates through two geographical segments: New Zealand and Australia.
Calendar
2024-08-05
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -39.29% | 2.3M | |
| +46.09% | 375M | |
| +30.93% | 313M | |
| +53.49% | 220M | |
| -28.99% | 183M | |
| +56.76% | 171M | |
| -28.57% | 144M | |
| +148.33% | 123M | |
| +3.85% | 106M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- GFI Stock
- News Greenfern Industries Limited
- Greenfern Industries Ships First Batch of Medicinal Cannabis to Europe, UK
